Difference between revisions of "Wolf Peter"
From Bioblast
Beno Marija (talk | contribs) |
Beno Marija (talk | contribs) |
||
Line 2: | Line 2: | ||
|lastname=Wolf | |lastname=Wolf | ||
|firstname=Peter | |firstname=Peter | ||
|title=Dr. Chief Scientific Officer (CSO) and Head of Assay Development | |title=Dr. | ||
|institution=[[File:Dr. Peter Wolf.jpg|right|180px|Peter Wolf]] INCYTON GmbH Innovation and Start-Up Center for Biotechnology | Chief Scientific Officer (CSO) and Head of Assay Development | ||
|institution=[[File:Dr. Peter Wolf.jpg|right|180px|Peter Wolf]] INCYTON GmbH, | |||
Innovation and Start-Up Center for Biotechnology | |||
|address=Am Klopferspitz19A | |address=Am Klopferspitz19A | ||
|area code=82152 | |area code=82152 |
Latest revision as of 09:54, 14 April 2022
Name | Wolf Peter, Dr.
Chief Scientific Officer (CSO) and Head of Assay Development |
---|---|
Institution | INCYTON GmbH,
Innovation and Start-Up Center for Biotechnology |
Address | Am Klopferspitz19A, 82152 |
City | Planegg/Martinsried |
State/Province | |
Country | Germany |
peter.wolf@incyton.com | |
Weblink | https://www.incyton.com/ |
O2k-Network Lab |
Labels:
Publications
Published | Reference | |
---|---|---|
Heichler 2022 MitoFit | 2022 | Heichler C, Nagy M, Wolf P (2022) Evaluation of hepatotoxic effects of acetaminophen on HepG2 cells by parallel real-time monitoring in a multi-sensor analysis platform for automated cell-based assays. https://doi.org/10.26124/mitofit:2022-0006 — 2022-07-06 published in Bioenerg Commun 2022.6. |
Heichler 2022 BEC | 2022 | Heichler C, Nagy M, Wolf P (2022) Evaluation of hepatotoxic effects of acetaminophen on HepG2 cells by parallel real-time monitoring in a multi-sensor analysis platform for automated cell-based assays. Bioenerg Commun 2022.6. https://doi.org/10.26124/bec:2022-0006 |
Abstracts
Published | Reference | |
---|---|---|
Wolf 2022 Abstract Bioblast | 2022 | 5.4. «10+5» Heichler C, Nagy M, Wolf Peter (2022) Physiometabolic RTCA on an automated platform for short and long term applications. Bioblast 2022: BEC Inaugural Conference. In: https://doi.org/10.26124/bec:2022-0001 »Bioenergetics Communications« |